← Back to Analyst Consensus 
AKTX Buy
Akari Therapeutics Plc
Current Price —
Implied Upside —
Analysts 10
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 11, 2026 (15 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jul 20, 2026 | Maxim Group | upgrade | Hold → Buy | — | 42% |
| Apr 8, 2026 | Maxim Group | downgrade | Buy → Hold | — | 42% |
| Apr 1, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jan 5, 2026 | Ladenburg Thalmann | initiate | — → Buy | $1 | 45% |
| Sep 9, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $1.6 | 44% |
| Jul 18, 2025 | Maxim Group | initiate | — → Buy | $5 | 42% |
Price Target Trend
Apr 16, 2026 Oct 26, 2026
EPS Estimates
0q —
+1q —
+1y —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days